Djulbegovic Mak B, Uversky Vladimir N, Karp Carol L, Harbour J William
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17th St, Miami, FL 33136, USA.
Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Bruce B. Downs Blvd., MDC07, Tampa, FL 33612, USA; Center for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Institutskiy pereulok, 9, Dolgoprudny, 141700, Moscow region, Russia.
Int J Biol Macromol. 2022 Jan 15;195:93-101. doi: 10.1016/j.ijbiomac.2021.11.120. Epub 2021 Nov 24.
Mutations in the titin (TTN) gene are among the most common genomic aberrations in ocular surface squamous neoplasia (OSSN), the most common cancer of the external eye. Further, TTN mutations are associated with resistance to standard therapy with topical interferon alpha-2b (IFN-α2b). However, it remains unclear how TTN mutations drive OSSN pathogenesis and treatment resistance. TTN encodes the largest protein in the human body and its best understood function is as a myofibril scaffold in striated muscle. However, recent evidence indicates that TTN has additional functions in non-muscle cells and in cancer. Here, we performed a disorder-based bioinformatics analysis which revealed that intrinsically disordered protein regions are abundant in TTN and provide mechanistic insights into its function as a nuclear protein in epithelial cells. Specific mutations found in OSSN are predicted to affect its intrinsically disordered protein regions (IDPRs), promoting chromosomal instability, oncogenesis, and altered response to IFN-α2b treatment.
肌联蛋白(TTN)基因的突变是眼表鳞状上皮肿瘤(OSSN)中最常见的基因组畸变之一,OSSN是外眼最常见的癌症。此外,TTN突变与局部干扰素α-2b(IFN-α2b)标准治疗的耐药性有关。然而,目前尚不清楚TTN突变如何驱动OSSN的发病机制和治疗耐药性。TTN编码人体中最大的蛋白质,其最广为人知的功能是作为横纹肌中的肌原纤维支架。然而,最近的证据表明,TTN在非肌肉细胞和癌症中具有额外的功能。在这里,我们进行了基于无序的生物信息学分析,结果显示TTN中富含内在无序的蛋白质区域,并为其作为上皮细胞中核蛋白的功能提供了机制性见解。预计在OSSN中发现的特定突变会影响其内在无序的蛋白质区域(IDPR),从而促进染色体不稳定、肿瘤发生以及对IFN-α2b治疗反应的改变。